Regenerative technology for future therapy of erectile dysfunction.

about

Regenerative technology for future therapy of erectile dysfunction.

Item

http://www.wikidata.org/entity/Q36450791

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Regenerative technology for future therapy of erectile dysfunction.

@ast

Regenerative technology for future therapy of erectile dysfunction.

@en

type

Item

label

Regenerative technology for future therapy of erectile dysfunction.

@ast

Regenerative technology for future therapy of erectile dysfunction.

@en

prefLabel

Regenerative technology for future therapy of erectile dysfunction.

@ast

Regenerative technology for future therapy of erectile dysfunction.

@en

P1476

Regenerative technology for future therapy of erectile dysfunction.

@en

P2093

Ji-Kan Ryu

http://www.w3.org/2001/XMLSchema#string

Jun-Kyu Suh

http://www.w3.org/2001/XMLSchema#string

P2860

Angiogenesis therapy for the treatment of erectile dysfunction.

Expression of transforming growth factor-beta1 in penile tissue from rats with bilateral cavernosal nerve ablation.

The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential

Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse

Stem cell therapy for erectile dysfunction: a critical review.

Both immediate and delayed intracavernous injection of autologous adipose-derived stromal vascular fraction enhances recovery of erectile function in a rat model of cavernous nerve injury.

Emerging neuromodulatory molecules for the treatment of neurogenic erectile dysfunction caused by cavernous nerve injury.

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Hypoxia-specific gene expression for ischemic disease gene therapy.

Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of erectile dysfunction.

P304

173-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2223-4683.2012.07.01

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26816706

http://www.w3.org/2001/XMLSchema#string

P932

4708247

http://www.w3.org/2001/XMLSchema#string